Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
False
Advertisement
Small Molecules
The Secrets of the Gut
April 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
Trends and Challenges in Nitrosamine Testing Part Four The Regulatory Landscape
April 17, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
2 min read
Swallowing Safely: Evidence-Based Approaches to Tablets and Dysphagia
November 13, 2025
In stroke patients with dysphagia, the default practice of crushing tablets could increase residue, reduce efficacy, and raise aspiration risk...
5 min read
Navigating the Therapeutic Landscape of GERD
By Rob Coker
June 6, 2025
A glimpse into the research of one of the most prevalent gastrointestinal disorders worldwide, and how small molecule drug development is helping.
2 min read
This Week’s Biopharma News: Long-Running CRISPR Patent Case Reopened
By Rob Coker
May 15, 2025
Our latest news roundup reports on Trump's “most favored nation” order, the EMA’s investigation into finasteride and suicide, and Novo Nordisk’s continued R&D for obesity
4 min read
Facilities & Equipment
Technology & Manufacturing
Cell & Gene
Small Molecules
Blogs
Future of Pharma
Appreciating Academic Spinouts
By Rob Coker
May 14, 2025
Let us not forget the important role of academic spinouts in innovating across the modalities.
3 min read
A Small Molecule Drug Candidate for Alzheimer’s Treatment
May 9, 2025
Galimedix Therapeutics explains how small molecule drug candidates could provide new treatments for Alzheimer’s disease and beyond.
4 min read
This Week’s Biopharma News: EU Launches Initiative to Attract Scientists from US
By Stephanie Vine
May 7, 2025
Our latest news roundup reports on Novartis’ new acquisition, an NIH grant for an Alzheimer’s disease vaccine, and more
4 min read
Going From Benchtop Chemist to CEO: Part 2
By Stephanie Vine
April 21, 2025
In Part 1 of our interview with Simon Tasker, he explained how he joined Colorcon as a bench chemist – and never left...
5 min read
